Boothbay Fund Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.15M Sell
202,166
-116,673
-37% -$2.67M 0.05% 410
2026
Q1
$7.02M Buy
318,839
+148,814
+88% +$2.59M 0.09% 219
2025
Q4
$2M Sell
170,025
-36,219
-18% -$465K 0.03% 559
2025
Q3
$3.27M Sell
206,244
-24,107
-10% -$350K 0.05% 434
2025
Q2
$2.64M Buy
230,351
+85,094
+59% +$959K 0.05% 435
2025
Q1
$1.97M Buy
145,257
+52,515
+57% +$872K 0.05% 433
2024
Q4
$1.57M Buy
92,742
+5,413
+6% +$105K 0.04% 506
2024
Q3
$1.77M Buy
+87,329
New +$1.79M 0.04% 558
2021
Q3
– Sell
-11,794
Closed -$410K – 1914
2021
Q2
$410K Buy
+11,794
New +$391K 0.01% 1102
2019
Q4
– Sell
-19,215
Closed -$287K – 862
2019
Q3
$287K Buy
+19,215
New +$313K 0.03% 585

Other funds holding CC

Boothbay Fund Management's CC Position: Q2 2026 in Review

Boothbay Fund Management reduced its Chemours (CC) stake by 37% in Q2 2026, selling an estimated $2.67M and leaving 202,166 shares worth $4.15M. The position accounts for 0.05% of the portfolio, ranked #410.

Boothbay Fund Management first reported a position in CC in Q3 2019 and has held it in 10 quarters since. The position peaked at $7.02M in Q1 2026. 474 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Boothbay Fund Management held 202,166 shares of Chemours worth $4.15M as of Q2 2026.
  • Boothbay Fund Management sold 116,673 Chemours shares in Q2 2026, an estimated $2.67M.
  • Chemours made up 0.05% of Boothbay Fund Management's portfolio in Q2 2026, its #410 holding.
  • Boothbay Fund Management first reported a position in Chemours in Q3 2019 and has held it in 10 quarters since.
  • Boothbay Fund Management's Chemours position peaked at $7.02M in Q1 2026.
  • 474 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.